Need professional-grade analysis? Visit stockanalysis.com
$43.43B
21.88
1,417
N/A
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) trades on SHG in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY97.58, down 1.74% from the previous close.
Over the past year, 688578 has traded between a low of CNY82.76 and a high of CNY117.89. The stock has gained 9.1% over this period. It is currently 17.2% below its 52-week high.
Shanghai Allist Pharmaceuticals Co. Ltd. A has a market capitalization of $43.43B, with a price-to-earnings ratio of 21.88.
Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China. Its lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC), as well as for treating adult patients with locally advanced or metastatic NSCLC. The company was founded in 2004 and is based in Shanghai, China.
Side-by-side comparison against top Healthcare peers.